Acasti Pharma Year End Results

LAVAL, Quebec, May 30, 2011 (GLOBE NEWSWIRE) -- Acasti Pharma ("Acasti") (TSX-V:APO), a Neptune Technologies & Bioressources Inc's ("Neptune") subsidiary, today reports its consolidated financial results for the fiscal year ended February 28, 2011.
MORE ON THIS TOPIC